Evidence map›Paper›PMID 27702899›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer's disease.

Xiuming Zhang, Elizabeth C Mormino, Nanbo Sun, Reisa A Sperling, Mert R Sabuncu, B T Thomas Yeo, Alzheimer’s Disease Neuroimaging Initiative

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 112 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
112citing papers in PubMed, 1 pooled it
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

112 citing papers in PubMed, 1 synthesis or guideline pooled it, 189 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

52 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Xiuming ZhangDepartment of Electrical and Computer Engineering, Agency for Science, Technology and Research-National University of Singapore Clinical Imaging Research Centre, Singapore Institute for Neurotechnology and Memory Networks Program, National University of Singapore, Singapore 117599.
Elizabeth C MorminoDepartment of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA 02129.
Nanbo SunDepartment of Electrical and Computer Engineering, Agency for Science, Technology and Research-National University of Singapore Clinical Imaging Research Centre, Singapore Institute for Neurotechnology and Memory Networks Program, National University of Singapore, Singapore 117599.
Reisa A SperlingDepartment of Neurology, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA 02129.
Mert R SabuncuMartinos Center for Biomedical Imaging, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA 02129; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02138.
B T Thomas YeoDepartment of Electrical and Computer Engineering, Agency for Science, Technology and Research-National University of Singapore Clinical Imaging Research Centre, Singapore Institute for Neurotechnology and Memory Networks Program, National University of Singapore, Singapore 117599; Martinos Center for Biomedical Imaging, Massachusetts General Hospital/Harvard Medical School, Charlestown, MA 02129; Centre for Cognitive Neuroscience, Duke-National University of Singapore Graduate Medical School, Singapore 169857 thomas.yeo@nus.edu.sg.
Alzheimer’s Disease Neuroimaging Initiative
Harvard University · USAgency for Science, Technology and Research · SG

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Vascular factors, physical activity, and inflammation as modulators of neurodegenerative and cognitive trajectories (Project 2)P01AG036694 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Rachel Frances Buckley, Keith A. Johnson · 2010 to 2026
$50.2M
VASCULAR RISK AND COGNITIVE STATUS IN A LATINO POPULATIONP50AG005142 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BRASKIE, MEREDITH NICOLE · 1985 to 2019
$41.0M
Project 4P41EB015896 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2012 to 2018
$9.8M
University of Florida - Mt. Sinai Medical Center AD Research CenterP50AG047266 · NIA · UNIVERSITY OF FLORIDA · PI LOEWENSTEIN, DAVID · 2015 to 2019
$7.3M
A Storage Area Network for Structural and Functional Image AnalysisS10RR023401 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI FISCHL, BRUCE · 2009 to 2009
$2.0M
SILICON GRAPHICS PRISM EXTREME 128P/1TBS10RR023043 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI SORENSEN, ALMA GREGORY · 2006 to 2006
$1.5M
Multivariate Pattern Analysis Methods for Neuroimaging Genetics StudiesK25EB013649 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI SABUNCU, MERT RORY · 2011 to 2015
$877k
Influence of genetic risk factors on biomarkers and cognitive decline in preclinical ADK01AG051718 · NIA · STANFORD UNIVERSITY · PI MORMINO, ELIZABETH · 2016 to 2020
$642k
Computeserver Structural &Functional Image AnalysisS10RR019307 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI FISCHL, BRUCE · 2004 to 2004
$496k
Multi-modal Prediction of Future Clinical DementiaR21AG050122 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI VAN LEEMPUT, KOEN · 2016 to 2017
$470k
NCRR NIH HHS S10 RR019307NCRR NIH HHS S10 RR023043NCRR NIH HHS S10 RR023401NIA NIH HHS F32 AG044054NIA NIH HHS K01 AG051718NIA NIH HHS P01 AG036694NIA NIH HHS P50 AG005142NIA NIH HHS P50 AG047266NIA NIH HHS R21 AG050122NIA NIH HHS R41 AG052246NIA NIH HHS U01 AG024904NIA NIH HHS U24 AG021886NIBIB NIH HHS K25 EB013649NIBIB NIH HHS P41 EB015896
6 · The paper itself

Abstract

We used a data-driven Bayesian model to automatically identify distinct latent factors of overlapping atrophy patterns from voxelwise structural MRIs of late-onset Alzheimer's disease (AD) dementia patients. Our approach estimated the extent to which multiple distinct atrophy patterns were expressed within each participant rather than assuming that each participant expressed a single atrophy factor. The model revealed a temporal atrophy factor (medial temporal cortex, hippocampus, and amygdala), a subcortical atrophy factor (striatum, thalamus, and cerebellum), and a cortical atrophy factor (frontal, parietal, lateral temporal, and lateral occipital cortices). To explore the influence of each factor in early AD, atrophy factor compositions were inferred in beta-amyloid-positive (Aβ+) mild cognitively impaired (MCI) and cognitively normal (CN) participants. All three factors were associated with memory decline across the entire clinical spectrum, whereas the cortical factor was associated with executive function decline in Aβ+ MCI participants and AD dementia patients. Direct comparison between factors revealed that the temporal factor showed the strongest association with memory, whereas the cortical factor showed the strongest association with executive function. The subcortical factor was associated with the slowest decline for both memory and executive function compared with temporal and cortical factors. These results suggest that distinct patterns of atrophy influence decline across different cognitive domains. Quantification of this heterogeneity may enable the computation of individual-level predictions relevant for disease monitoring and customized therapies. Factor compositions of participants and code used in this article are publicly available for future research.

Indexed as

Bayes TheoremCognitive DysfunctionAlzheimer DiseaseAtrophyBrainDementiaFemaleHumansMagnetic Resonance ImagingMaleRisk FactorsAlzheimer’s disease heterogeneityAlzheimer’s disease subtypesmental disorder subtypesunsupervised machine learningvoxel-based morphometry

Identifiers

PMID27702899
PMCPMC5081632
OpenAlexW2528250414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.